Science Explorer Back to mapMap
Discussion
Company · Berkeley · United States

ActiveSite Pharmaceuticals (United States)

activesitepharma.comROR OpenAlex
Research works
15
▲ 79% vs 2018-21
Citations
1.3k
86.5 per fractional work
Top-10% rate
10.2%
all institutions 10.0%
Open access
54%
world 40%
International
26%
world 18%
ActiveSite Pharmaceuticals (United States)

Not ranked overall: ActiveSite Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ActiveSite Pharmaceuticals (United States) work in?

In all years, 65% of research at ActiveSite Pharmaceuticals (United States) is in Life Sciences, 32% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (40%), Medicine (31%), Neuroscience (21%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 64.7% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 40.3% of its workMolecular Biology: 5 fractional works · 33.8% of its workBiotechnology: 1 fractional works · 4.4% of its workGenetics: 0 fractional works · 1.1% of its workClinical Biochemistry: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.4% of its workNeuroscience: 3 fractional works · 20.7% of its workCellular and Molecular Neuroscience: 3 fractional works · 20.7% of its workImmunology and Microbiology: 0 fractional works · 2.9% of its workImmunology: 0 fractional works · 2.9% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 5 fractional works · 31.7% of its workMedicine: 5 fractional works · 30.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 3.8% of its workOphthalmology: 1 fractional works · 3.6% of its workOncology: 0 fractional works · 3.3% of its workGenetics: 0 fractional works · 3.1% of its workHematology: 0 fractional works · 2.9% of its workImmunology and Allergy: 0 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.6% of its workPhysiology: 0 fractional works · 1.2% of its workNeurology: 0 fractional works · 1.1% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 1.1% of its workNutrition and Dietetics: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 2.1% of its workArts and Humanities: 0 fractional works · 1.4% of its workLanguage and Linguistics: 0 fractional works · 0.7% of its workPhilosophy: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.7% of its workLinguistics and Language: 0 fractional works · 0.7% of its workPhysical Sciences: 0 fractional works · 1.4% of its workChemistry: 0 fractional works · 0.5% of its workSpectroscopy: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workEngineering: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workALL ITS WORKActiveSitePharmaceuticals…15fractional works, all years
Life Sciences65%Physical Sciences1%Health Sciences32%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology640.3%
    2. Neuroscience320.7%
    3. Immunology and Microbiology02.9%
    4. Agricultural and Biological Sciences00.9%
    1. Medicine530.6%
    2. Nursing01.1%
    1. Arts and Humanities01.4%
    2. Social Sciences00.7%
    1. Chemistry00.5%
    2. Computer Science00.5%
    3. Engineering00.2%
    4. Environmental Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from ActiveSite Pharmaceuticals (United States)?

The most cited paper from ActiveSite Pharmaceuticals (United States) is "Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6" (Juan Antonio Ballesteros‐Cánovas, Anne Dam Jensen, George Liapakis et al., 2001), with 622 citations. Next come "Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like Receptors" (440) and "β2 Adrenergic Receptor Activation" (429).

Most cited papers
#PaperReleasedCitations
1 Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6 Juan Antonio Ballesteros‐Cánovas, Anne Dam Jensen, George Liapakis et al. · Journal of Biological Chemistry Open access Aug 2001 622
2 Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like Receptors Juan Antonio Ballesteros‐Cánovas, Lei Shi, Jonathan A. Javitch · Molecular Pharmacology Jul 2001 440
3 β2 Adrenergic Receptor Activation Lei Shi, George Liapakis, Rui Xu et al. · Journal of Biological Chemistry Open access Oct 2002 429
4 Regulation of vertebrate eye development by Rx genes Travis J. Bailey, Heithem M. El‐Hodiri, Li Zhang et al. · The International Journal of Developmental Biology Open access 2004 177
5 Agonist-induced Conformational Changes at the Cytoplasmic Side of Transmembrane Segment 6 in the β2 Adrenergic Receptor Mapped by Site-selective Fluorescent Labeling Anne Dam Jensen, Frank Guarnieri, Søren G. F. Rasmussen et al. · Journal of Biological Chemistry Open access Mar 2001 144
All 27 most cited papers, with filters and sorting

Which research topics does ActiveSite Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Radiation Therapy and Dosimetry, PARP inhibition in cancer therapy, Radiopharmaceutical Chemistry and Applications and Water-Energy-Food Nexus Studies.

Radiation Therapy and Do…0Radiation Therapy and Dosimetry: 0 fractional worksPARP inhibition in cance…0PARP inhibition in cancer therapy: 0 fractional worksRadiopharmaceutical Chem…0Radiopharmaceutical Chemistry and Applications: 0 fractional works
Pulmonary and Respiratory MedicineOncologyRadiology, Nuclear Medicine and Imaging

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 0 works
  2. 2 PARP inhibition in cancer therapy Oncology 0 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Water-Energy-Food Nexus Studies Water Science and Technology 0 works
  5. 5 Irrigation Practices and Water Management Soil Science 0 works
  6. 6 Water resources management and optimization Ocean Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.9%not open46.1%

World: 40% of research is openly available.

with international co-authors25.7%domestic only74.3%

World: 18% is written across borders.

How has ActiveSite Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 79% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ActiveSite Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000078% in 2018.

still counting0.00020%0.00040%ActiveSite Pharmaceuticals (United States)0.000010% in 202520102020

Fractional works of ActiveSite Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Berkeley

All research institutions in Berkeley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ActiveSite Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.